Microphysiological modeling of the reproductive tract: A fertile endeavor

Sharon L. Eddie, J. Julie Kim, Teresa K. Woodruff, Joanna E. Burdette

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Preclinical toxicity testing in animal models is a cornerstone of the drug development process, yet it is often unable to predict adverse effects and tolerability issues in human subjects. Species-specific responses to investigational drugs have led researchers to utilize human tissues and cells to better estimate human toxicity. Unfortunately, human cell-derived models are imperfect because toxicity is assessed in isolation, removed from the normal physiologic microenvironment. Microphysiological modeling often referred to as 'organ-on-a-chip' or 'human-on-a-chip' places human tissue into a microfluidic system that mimics the complexity of human in vivo physiology, thereby allowing for toxicity testing on several cell types, tissues, and organs within a more biologically relevant environment. Here we describe important concepts when developing a repro-on-a-chip model. The development of female and male reproductive microfluidic systems is critical to sex-based in vitro toxicity and drug testing. This review addresses the biological and physiological aspects of the male and female reproductive systems in vivo and what should be considered when designing a microphysiological human-on-a-chip model. Additionally, interactions between the reproductive tract and other systems are explored, focusing on the impact of factors and hormones produced by the reproductive tract and disease pathophysiology.

Original languageEnglish
Pages (from-to)1192-202
Number of pages11
JournalExperimental Biology and Medicine
Volume239
Issue number9
Early online date15 Apr 2014
DOIs
Publication statusPublished - Sep 2014

Fingerprint

Toxicity
Tissue
Microfluidics
Testing
Investigational Drugs
Physiology
Pharmaceutical Preparations
Animals
Cells
Hormones
Drug-Related Side Effects and Adverse Reactions
Animal Models
Research Personnel

Keywords

  • Animals
  • Drug Evaluation, Preclinical
  • Female
  • Genitalia, Female
  • Genitalia, Male
  • Humans
  • Lab-On-A-Chip Devices
  • Male
  • Models, Biological
  • Tissue Culture Techniques

Cite this

Eddie, Sharon L. ; Kim, J. Julie ; Woodruff, Teresa K. ; Burdette, Joanna E. / Microphysiological modeling of the reproductive tract: A fertile endeavor. In: Experimental Biology and Medicine . 2014 ; Vol. 239, No. 9. pp. 1192-202.
@article{807d59daa9394aacbbd2d7a615d08f33,
title = "Microphysiological modeling of the reproductive tract: A fertile endeavor",
abstract = "Preclinical toxicity testing in animal models is a cornerstone of the drug development process, yet it is often unable to predict adverse effects and tolerability issues in human subjects. Species-specific responses to investigational drugs have led researchers to utilize human tissues and cells to better estimate human toxicity. Unfortunately, human cell-derived models are imperfect because toxicity is assessed in isolation, removed from the normal physiologic microenvironment. Microphysiological modeling often referred to as 'organ-on-a-chip' or 'human-on-a-chip' places human tissue into a microfluidic system that mimics the complexity of human in vivo physiology, thereby allowing for toxicity testing on several cell types, tissues, and organs within a more biologically relevant environment. Here we describe important concepts when developing a repro-on-a-chip model. The development of female and male reproductive microfluidic systems is critical to sex-based in vitro toxicity and drug testing. This review addresses the biological and physiological aspects of the male and female reproductive systems in vivo and what should be considered when designing a microphysiological human-on-a-chip model. Additionally, interactions between the reproductive tract and other systems are explored, focusing on the impact of factors and hormones produced by the reproductive tract and disease pathophysiology.",
keywords = "Animals, Drug Evaluation, Preclinical, Female, Genitalia, Female, Genitalia, Male, Humans, Lab-On-A-Chip Devices, Male, Models, Biological, Tissue Culture Techniques",
author = "Eddie, {Sharon L.} and Kim, {J. Julie} and Woodruff, {Teresa K.} and Burdette, {Joanna E.}",
year = "2014",
month = "9",
doi = "10.1177/1535370214529387",
language = "English",
volume = "239",
pages = "1192--202",
journal = "Experimental Biology and Medicine",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "9",

}

Microphysiological modeling of the reproductive tract: A fertile endeavor. / Eddie, Sharon L.; Kim, J. Julie; Woodruff, Teresa K.; Burdette, Joanna E.

In: Experimental Biology and Medicine , Vol. 239, No. 9, 09.2014, p. 1192-202.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microphysiological modeling of the reproductive tract: A fertile endeavor

AU - Eddie, Sharon L.

AU - Kim, J. Julie

AU - Woodruff, Teresa K.

AU - Burdette, Joanna E.

PY - 2014/9

Y1 - 2014/9

N2 - Preclinical toxicity testing in animal models is a cornerstone of the drug development process, yet it is often unable to predict adverse effects and tolerability issues in human subjects. Species-specific responses to investigational drugs have led researchers to utilize human tissues and cells to better estimate human toxicity. Unfortunately, human cell-derived models are imperfect because toxicity is assessed in isolation, removed from the normal physiologic microenvironment. Microphysiological modeling often referred to as 'organ-on-a-chip' or 'human-on-a-chip' places human tissue into a microfluidic system that mimics the complexity of human in vivo physiology, thereby allowing for toxicity testing on several cell types, tissues, and organs within a more biologically relevant environment. Here we describe important concepts when developing a repro-on-a-chip model. The development of female and male reproductive microfluidic systems is critical to sex-based in vitro toxicity and drug testing. This review addresses the biological and physiological aspects of the male and female reproductive systems in vivo and what should be considered when designing a microphysiological human-on-a-chip model. Additionally, interactions between the reproductive tract and other systems are explored, focusing on the impact of factors and hormones produced by the reproductive tract and disease pathophysiology.

AB - Preclinical toxicity testing in animal models is a cornerstone of the drug development process, yet it is often unable to predict adverse effects and tolerability issues in human subjects. Species-specific responses to investigational drugs have led researchers to utilize human tissues and cells to better estimate human toxicity. Unfortunately, human cell-derived models are imperfect because toxicity is assessed in isolation, removed from the normal physiologic microenvironment. Microphysiological modeling often referred to as 'organ-on-a-chip' or 'human-on-a-chip' places human tissue into a microfluidic system that mimics the complexity of human in vivo physiology, thereby allowing for toxicity testing on several cell types, tissues, and organs within a more biologically relevant environment. Here we describe important concepts when developing a repro-on-a-chip model. The development of female and male reproductive microfluidic systems is critical to sex-based in vitro toxicity and drug testing. This review addresses the biological and physiological aspects of the male and female reproductive systems in vivo and what should be considered when designing a microphysiological human-on-a-chip model. Additionally, interactions between the reproductive tract and other systems are explored, focusing on the impact of factors and hormones produced by the reproductive tract and disease pathophysiology.

KW - Animals

KW - Drug Evaluation, Preclinical

KW - Female

KW - Genitalia, Female

KW - Genitalia, Male

KW - Humans

KW - Lab-On-A-Chip Devices

KW - Male

KW - Models, Biological

KW - Tissue Culture Techniques

U2 - 10.1177/1535370214529387

DO - 10.1177/1535370214529387

M3 - Article

C2 - 24737736

VL - 239

SP - 1192

EP - 1202

JO - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 1535-3702

IS - 9

ER -